Another rapid-Covid-19 test has received emergency authorization approval from the Food and Drug Administration.
LabCorp (LH) - Get Report on Friday said that it has received the go-ahead from the FDA for a new type of high-speed Covid-19 test that uses heat and technology to extract RNA from samples collected for Covid-19 molecular testing.
LabCorp says its testing methodology, which uses heat to trap viral particles that can be tested for the disease, “…helps improve the speed and efficiency of RT-PCR tests, considered the ‘gold standard’ for active infections.
LabCorp already makes short nasal swab Covid-19 tests for at-home collection that provide results in 24 hours.
The announcement came on the same day that U.S. President Donald Trump and his wife, first lady Melania Trump, revealed they have contracted Covid-19.
The president’s diagnosis, the most serious known health threat to a sitting American president in decades, comes as global cases of Covid-19 pass 34 million. More than 1 million individuals have perished from the disease, including 207,808 in the U.S. as of Friday, according to figures compiled by John Hopkins University.
Watch More on the Coronavirus Pandemic From TheStreet.com:
- Coronavirus Update: Eli Lilly and Amgen to Manufacture Possible COVID-19 Drugs
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- Jim Cramer: 11 Days Is Too Long for Eli Lilly's Antibody Treatment to Work
- Is Amazon Coronavirus-Proof?